Baseline | Follow-up | Change between baseline and follow up | P value | ||||||
---|---|---|---|---|---|---|---|---|---|
Exenatide (n = 19) | Control (n = 17) | P value | Exenatide (n = 16) | Control (n = 17) | P value | Exenatide (n = 15) | Control (n = 17) | P value | |
Strut analysis | |||||||||
Covered struts per lesion, % | – | – | – | 95.0 (88.7–98.5) | 91.4 (88.8–98.5) | 0.692a | – | – | – |
Covered struts > 40 µm, % | 79.4 (35.0–95.0) | 64 (34.3–90.5) | 0.589a | ||||||
Malapposition > 300 µm,% | 0.8 (1.5) | 1.5 (2.7) | 0.347b | 0.4 (0.8) | 1.4 (4.2) | 0.368b | − 0.2 (1.2) | − 0.0 (2.5) | 0.829b |
Malapposition volume, mm3 | 11 (4.8) | 13.5 (8.4) | 0.285b | 2.2 (2.6) | 3.7 (5.3) | 0.322b | − 9 (5.4) | − 9.2 (7.5) | 0.892b |
Mean NIH area, mm2 | – | – | – | 1.3 (0.4) | 1.1 (0.5) | 0.423b | – | – | – |
NIH area at maximal obstruction, mm2 | – | – | – | 1.2 (1–2.3) | 1.1 (0.7–1.9) | 0.407a | – | – | – |
NIH stenosis, % | – | – | – | 15.5 (10.6–19.2) | 14.7 (11–17.1) | 0.801a | – | – | – |
NIH volume at maximal obstruction, mm3 | – | – | – | 33.8 (20) | 33.8 (17.4) | 1.000b | – | – | – |
Maximal neo-intimal thickness at maximal obstruction, mm | – | – | – | 0.2 (0.1–0.3) | 0.2 (0.1–0.6) | 0.471a | – | – | – |
Total number of struts analyzed per lesion, n | 2031 (664) | 2545.5 (1187) | 0.113b | 2154 (924) | 2579 (1380) | 0.304b | |||
Number of struts per cross-section, n | 10.2 (1.6) | 10.3 (1.4) | 0.863b | 10.9 (1.6) | 10.6 (1.6) | 0.690b | |||
Stenosis segment | |||||||||
Minimum lumen diameter at maximal obstruction, mm | 2.4 (0.4) | 2.3 (0.5) | 0.464b | 2.3 (0.5) | 2.1 (0.6) | 0.517b | − 0.2 (0.4) | − 0.2 (0.4) | 0.798b |
Mean in-stent minimal lumen diameter, mm | 2.9 (0.4) | 2.7 (0.4) | 0.261b | 2.8 (0.4) | 2.7 (0.5) | 0.382b | − 0.1 (0.2) | − 0.0 (0.2) | 0.165b |
CS lumen area at maximal obstruction, mm2 | 6.1 (1.8) | 5.1 (1.8) | 0.122b | 5 (2) | 4.4 (2.2) | 0.362b | − 0.6 (− 0.2–1.6) | − 0.6 (0.3–1.0) | 0.635a |
Lumen area stenosis (mean area as reference), % | 23.2 (3.6–32.7) | 17.3 (10–27.8) | 0.692a | 30.4 (17.7–46.3) | 32.7 (18.2–46.1) | 0.857a | 13.7 (3.6–24.6) | 12.6 (− 5–29.5) | 0.813a |
CS stent area at maximal obstruction, mm2 | 6.1 (1.8) | 5.1 (1.8) | 0.097b | 6.6 (2.1) | 5.8 (2.1) | 0.272b | 0.2 (1.8) | 0.9 (1.0) | 0.231b |
Mean in-stent CS area, mm2 | 8.1 (2.2) | 7 (2.0) | 0.134b | 7.6 (1.9) | 6.9 (2.7) | 0.885b | 0.3 (1) | 1.1 (1.0) | 0.054b |
In-stent lumen volume, mm3 | 204.7 (155.8–296) | 192.2 (154.9–283.7) | 0.937a | 246.8 (155.3–276) | 187.1 (123.6–289) | 0.756a | − 17.8 (− 62.2–20.1) | − 2.6 (− 34–62.4) | 0.268a |
In-stent stent volume, mm3 | 157.4 (136–273) | 166.5 (104.8–258) | 0.537a | 228.9 (136.1–297.3) | 206.9 (145.3–312.3) | 0.971a | 13.4 (-36.3–71) | 48.5 (27.3–140.5) | 0.048a |